Skip to main content

Table 3 Frequency of priority selection and agreement level for funding scenarios (N = 1631)

From: Engaging the Canadian public on reimbursement decision-making for drugs for rare diseases: a national online survey

Priority Selection

Description

Frequency (%)

Improve Quality of Life

1304 (80.0)

Effective Health Care

1232 (75.5)

National Equal Access

701 (43.0)

Pain Reduction

642 (39.4)

Cost Containment

543 (33.3)

Severity of Symptoms

430 (26.4)

Longer Life

376 (23.1)

Lack of Current Treatment

372 (22.8)

Funding Scenario by Agreement Level

Description

Agreement Level

Frequency (%)

Canadawide Equality

Agree

1292 (79.2)

Neither agree nor disagree

229 (14.0)

Disagree

95 (5.8)

No response

15 (0.9)

Fund Drug if Justified

Agree

1190 (73.0)

Neither agree nor disagree

311 (19.1)

Disagree

115 (7.1)

No response

15 (0.9)

Pay for Drugs

Agree

818 (50.2)

Neither agree nor disagree

484 (29.7)

Disagree

305 (18.7)

No response

24 (1.4)

Prioritize Other Programs

Agree

601 (36.8)

Neither agree nor disagree

549 (33.7

Disagree

460 (28.2)

No response

21 (1.3)

  1. Agree: 4 = agree and 5 = completely agree; Disagree: 1 = completely disagree and 2 = disagree; Neither agree nor disagree: 3 = neutral